The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Antibody Production-Global Market Insights and Sales Trends 2025
Synopsis
The global Antibody Production market size is expected to reach US$ 14630 million by 2029, growing at a CAGR of 7.0% from 2023 to 2029. The market is mainly driven by the significant applications of Antibody Production in various end use industries. The expanding demands from the Pharmaceutical and biotechnology companies, Research laboratories and Others,, are propelling Antibody Production market. Polyclonal antibody, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Monoclonal antibody segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Antibody Production market, driven by demand from China, the second largest economy with some signs of stabilising, the Antibody Production market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antibody Production, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antibody Production market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antibody Production market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antibody Production sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antibody Production covered in this report include Thermo Fisher Scientific, Inc., GE Healthcare, Sartorius AG, Merck KGaA, Eppendorf AG, Cellab GmbH, Pall Corp., INTEGRA Biosciences AG and FiberCell Systems Inc., etc.
The global Antibody Production market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher Scientific, Inc.
GE Healthcare
Sartorius AG
Merck KGaA
Eppendorf AG
Cellab GmbH
Pall Corp.
INTEGRA Biosciences AG
FiberCell Systems Inc.
Global Antibody Production market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antibody Production market, Segment by Type:
Polyclonal antibody
Monoclonal antibody
Murine
Chimeric
Humanized
Global Antibody Production market, by Application
Pharmaceutical and biotechnology companies
Research laboratories
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Antibody Production manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Antibody Production in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Antibody Production market size is expected to reach US$ 14630 million by 2029, growing at a CAGR of 7.0% from 2023 to 2029. The market is mainly driven by the significant applications of Antibody Production in various end use industries. The expanding demands from the Pharmaceutical and biotechnology companies, Research laboratories and Others,, are propelling Antibody Production market. Polyclonal antibody, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Monoclonal antibody segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Antibody Production market, driven by demand from China, the second largest economy with some signs of stabilising, the Antibody Production market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antibody Production, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antibody Production market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antibody Production market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antibody Production sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antibody Production covered in this report include Thermo Fisher Scientific, Inc., GE Healthcare, Sartorius AG, Merck KGaA, Eppendorf AG, Cellab GmbH, Pall Corp., INTEGRA Biosciences AG and FiberCell Systems Inc., etc.
The global Antibody Production market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher Scientific, Inc.
GE Healthcare
Sartorius AG
Merck KGaA
Eppendorf AG
Cellab GmbH
Pall Corp.
INTEGRA Biosciences AG
FiberCell Systems Inc.
Global Antibody Production market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antibody Production market, Segment by Type:
Polyclonal antibody
Monoclonal antibody
Murine
Chimeric
Humanized
Global Antibody Production market, by Application
Pharmaceutical and biotechnology companies
Research laboratories
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Antibody Production manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Antibody Production in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Antibody Production Market Overview
1.1 Antibody Production Product Overview
1.2 Antibody Production Market Segment by Type
1.2.1 Polyclonal antibody
1.2.2 Monoclonal antibody
1.2.3 Murine
1.2.4 Chimeric
1.2.5 Humanized
1.3 Global Antibody Production Market Size by Type
1.3.1 Global Antibody Production Market Size Overview by Type (2018-2029)
1.3.2 Global Antibody Production Historic Market Size Review by Type (2018-2023)
1.3.3 Global Antibody Production Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Antibody Production Sales Breakdown by Type (2018-2023)
1.4.2 Europe Antibody Production Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Antibody Production Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Antibody Production Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Antibody Production Sales Breakdown by Type (2018-2023)
2 Global Antibody Production Market Competition by Company
2.1 Global Top Players by Antibody Production Sales (2018-2023)
2.2 Global Top Players by Antibody Production Revenue (2018-2023)
2.3 Global Top Players by Antibody Production Price (2018-2023)
2.4 Global Top Manufacturers Antibody Production Manufacturing Base Distribution, Sales Area, Product Type
2.5 Antibody Production Market Competitive Situation and Trends
2.5.1 Antibody Production Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Antibody Production Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antibody Production as of 2022)
2.7 Date of Key Manufacturers Enter into Antibody Production Market
2.8 Key Manufacturers Antibody Production Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Antibody Production Status and Outlook by Region
3.1 Global Antibody Production Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Antibody Production Historic Market Size by Region
3.2.1 Global Antibody Production Sales in Volume by Region (2018-2023)
3.2.2 Global Antibody Production Sales in Value by Region (2018-2023)
3.2.3 Global Antibody Production Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Antibody Production Forecasted Market Size by Region
3.3.1 Global Antibody Production Sales in Volume by Region (2024-2029)
3.3.2 Global Antibody Production Sales in Value by Region (2024-2029)
3.3.3 Global Antibody Production Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Antibody Production by Application
4.1 Antibody Production Market Segment by Application
4.1.1 Pharmaceutical and biotechnology companies
4.1.2 Research laboratories
4.1.3 Others
4.2 Global Antibody Production Market Size by Application
4.2.1 Global Antibody Production Market Size Overview by Application (2018-2029)
4.2.2 Global Antibody Production Historic Market Size Review by Application (2018-2023)
4.2.3 Global Antibody Production Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Antibody Production Sales Breakdown by Application (2018-2023)
4.3.2 Europe Antibody Production Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Antibody Production Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Antibody Production Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Antibody Production Sales Breakdown by Application (2018-2023)
5 North America Antibody Production by Country
5.1 North America Antibody Production Historic Market Size by Country
5.1.1 North America Antibody Production Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Antibody Production Sales in Volume by Country (2018-2023)
5.1.3 North America Antibody Production Sales in Value by Country (2018-2023)
5.2 North America Antibody Production Forecasted Market Size by Country
5.2.1 North America Antibody Production Sales in Volume by Country (2024-2029)
5.2.2 North America Antibody Production Sales in Value by Country (2024-2029)
6 Europe Antibody Production by Country
6.1 Europe Antibody Production Historic Market Size by Country
6.1.1 Europe Antibody Production Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Antibody Production Sales in Volume by Country (2018-2023)
6.1.3 Europe Antibody Production Sales in Value by Country (2018-2023)
6.2 Europe Antibody Production Forecasted Market Size by Country
6.2.1 Europe Antibody Production Sales in Volume by Country (2024-2029)
6.2.2 Europe Antibody Production Sales in Value by Country (2024-2029)
7 Asia-Pacific Antibody Production by Region
7.1 Asia-Pacific Antibody Production Historic Market Size by Region
7.1.1 Asia-Pacific Antibody Production Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Antibody Production Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Antibody Production Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Antibody Production Forecasted Market Size by Region
7.2.1 Asia-Pacific Antibody Production Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Antibody Production Sales in Value by Region (2024-2029)
8 Latin America Antibody Production by Country
8.1 Latin America Antibody Production Historic Market Size by Country
8.1.1 Latin America Antibody Production Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Antibody Production Sales in Volume by Country (2018-2023)
8.1.3 Latin America Antibody Production Sales in Value by Country (2018-2023)
8.2 Latin America Antibody Production Forecasted Market Size by Country
8.2.1 Latin America Antibody Production Sales in Volume by Country (2024-2029)
8.2.2 Latin America Antibody Production Sales in Value by Country (2024-2029)
9 Middle East and Africa Antibody Production by Country
9.1 Middle East and Africa Antibody Production Historic Market Size by Country
9.1.1 Middle East and Africa Antibody Production Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Antibody Production Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Antibody Production Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Antibody Production Forecasted Market Size by Country
9.2.1 Middle East and Africa Antibody Production Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Antibody Production Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Thermo Fisher Scientific, Inc.
10.1.1 Thermo Fisher Scientific, Inc. Company Information
10.1.2 Thermo Fisher Scientific, Inc. Introduction and Business Overview
10.1.3 Thermo Fisher Scientific, Inc. Antibody Production Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Thermo Fisher Scientific, Inc. Antibody Production Products Offered
10.1.5 Thermo Fisher Scientific, Inc. Recent Development
10.2 GE Healthcare
10.2.1 GE Healthcare Company Information
10.2.2 GE Healthcare Introduction and Business Overview
10.2.3 GE Healthcare Antibody Production Sales, Revenue and Gross Margin (2018-2023)
10.2.4 GE Healthcare Antibody Production Products Offered
10.2.5 GE Healthcare Recent Development
10.3 Sartorius AG
10.3.1 Sartorius AG Company Information
10.3.2 Sartorius AG Introduction and Business Overview
10.3.3 Sartorius AG Antibody Production Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Sartorius AG Antibody Production Products Offered
10.3.5 Sartorius AG Recent Development
10.4 Merck KGaA
10.4.1 Merck KGaA Company Information
10.4.2 Merck KGaA Introduction and Business Overview
10.4.3 Merck KGaA Antibody Production Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Merck KGaA Antibody Production Products Offered
10.4.5 Merck KGaA Recent Development
10.5 Eppendorf AG
10.5.1 Eppendorf AG Company Information
10.5.2 Eppendorf AG Introduction and Business Overview
10.5.3 Eppendorf AG Antibody Production Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Eppendorf AG Antibody Production Products Offered
10.5.5 Eppendorf AG Recent Development
10.6 Cellab GmbH
10.6.1 Cellab GmbH Company Information
10.6.2 Cellab GmbH Introduction and Business Overview
10.6.3 Cellab GmbH Antibody Production Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Cellab GmbH Antibody Production Products Offered
10.6.5 Cellab GmbH Recent Development
10.7 Pall Corp.
10.7.1 Pall Corp. Company Information
10.7.2 Pall Corp. Introduction and Business Overview
10.7.3 Pall Corp. Antibody Production Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Pall Corp. Antibody Production Products Offered
10.7.5 Pall Corp. Recent Development
10.8 INTEGRA Biosciences AG
10.8.1 INTEGRA Biosciences AG Company Information
10.8.2 INTEGRA Biosciences AG Introduction and Business Overview
10.8.3 INTEGRA Biosciences AG Antibody Production Sales, Revenue and Gross Margin (2018-2023)
10.8.4 INTEGRA Biosciences AG Antibody Production Products Offered
10.8.5 INTEGRA Biosciences AG Recent Development
10.9 FiberCell Systems Inc.
10.9.1 FiberCell Systems Inc. Company Information
10.9.2 FiberCell Systems Inc. Introduction and Business Overview
10.9.3 FiberCell Systems Inc. Antibody Production Sales, Revenue and Gross Margin (2018-2023)
10.9.4 FiberCell Systems Inc. Antibody Production Products Offered
10.9.5 FiberCell Systems Inc. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Antibody Production Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Antibody Production Industrial Chain Analysis
11.4 Antibody Production Market Dynamics
11.4.1 Antibody Production Industry Trends
11.4.2 Antibody Production Market Drivers
11.4.3 Antibody Production Market Challenges
11.4.4 Antibody Production Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Antibody Production Distributors
12.3 Antibody Production Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
